We successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to the Department of Health and Human Services Office of Inspector General (HHS-OIG) involving improper billing. Our team conducted an internal investigation into possible compliance issues, drafted the disclosure to HHS-OIG, and negotiated the final settlement between the parties resulting in a favorable resolution.
Successful Settlement with HHS-OIG on Behalf of a Private Equity Backed Portfolio Provider
You Also May Be Interested In:
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.
Served as lead counsel to BriovaRx Infusion Services in obtaining a Certificate of Need to expand services in Middle Tennessee